Cullen Capital Management
ABBV icon

Cullen Capital Management’s AbbVie ABBV Stock Holding History

Cullen Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.15M Buy
8,222
+1,070
+15% +$274K 0.02% 109
2026
Q2 		$1.8M Buy
7,152
+5,715
+398% +$1.23M 0.02% 116
2026
Q1 		$313K Sell
1,437
-560
-28% -$124K ﹤0.01% 190
2025
Q4 		$456K Buy
1,997
+750
+60% +$171K 0.01% 181
2025
Q3 		$289K Hold
1,247
– – ﹤0.01% 196
2025
Q2 		$231K Sell
1,247
-1,095
-47% -$204K ﹤0.01% 194
2025
Q1 		$491K Sell
2,342
-1,430
-38% -$278K 0.01% 156
2024
Q4 		$670K Hold
3,772
– – 0.01% 164
2024
Q3 		$745K Hold
3,772
– – 0.01% 141
2024
Q2 		$647K Hold
3,772
– – 0.01% 135
2024
Q1 		$687K Buy
3,772
+298
+9% +$51.4K 0.01% 127
2023
Q4 		$538K Buy
3,474
+234
+7% +$34.1K 0.01% 155
2023
Q3 		$483K Sell
3,240
-192
-6% -$28.2K 0.01% 140
2023
Q2 		$462K Hold
3,432
– – ﹤0.01% 234
2023
Q1 		$547K Sell
3,432
-88
-3% -$13.5K 0.01% 202
2022
Q4 		$569K Hold
3,520
– – 0.01% 154
2022
Q3 		$472K Buy
3,520
+280
+9% +$40.2K 0.01% 220
2022
Q2 		$496K Hold
3,240
– – 0.01% 219
2022
Q1 		$525K Sell
3,240
-369
-10% -$53.6K ﹤0.01% 216
2021
Q4 		$489K Buy
+3,609
New +$426K ﹤0.01% 232
2021
Q3 		– Sell
-3,525
Closed -$397K – 270
2021
Q2 		$397K Buy
3,525
+9
+0.3% +$1.01K ﹤0.01% 226
2021
Q1 		$381K Buy
+3,516
New +$376K ﹤0.01% 228

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Cullen Capital Management's ABBV Position: Q3 2026 in Review

Cullen Capital Management increased its AbbVie (ABBV) stake by 15% in Q3 2026, buying an estimated $274K and bringing the position to 8,222 shares worth $2.15M. The position accounts for 0.02% of the portfolio, ranked #109.

Cullen Capital Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cullen Capital Management held 8,222 shares of AbbVie worth $2.15M as of Q3 2026.
  • Cullen Capital Management bought 1,070 AbbVie shares in Q3 2026, an estimated $274K.
  • AbbVie made up 0.02% of Cullen Capital Management's portfolio in Q3 2026, its #109 holding.
  • Cullen Capital Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cullen Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.